TECH
Bio-Techne Delivers Strong Q3 Performance Amidst Uncertainty, Eyes Future Growth in Core Reagents and Cell Therapy Markets
Bio-Techne, a leading life science company, has reported a strong third quarter performance, with 6% organic revenue growth despite operating in a relatively uncertain macro environment. According to Kim Kelderman, President and Chief Executive Officer, the company delivered yet another strong quarter with an emphasis on profitability, driven by operational